Skip to main content

OPINION article

Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1384131
This article is part of the Research Topic Toward a Decision-Centric Precision Public Health: Clinical, Operational, and Analytical Advances View all 4 articles

Impediments to compliance during filariasis mass drug administration - observations and recommendations to accelerate filariasis elimination in India

Provisionally accepted
PHILIP R. ABRAHAM PHILIP R. ABRAHAM *Vijesh S. Kuttiatt Vijesh S. Kuttiatt Dr Manju Rahi Dr Manju Rahi Dr Ashwani Kumar Dr Ashwani Kumar
  • Vector Control Research Centre (ICMR), Puducherry, India

The final, formatted version of the article will be published soon.

    Keywords: Lymphatic filariasis elimination, outliers, MDA, IDA, Ineligible, Compliance

    Received: 08 Feb 2024; Accepted: 24 May 2024.

    Copyright: © 2024 ABRAHAM, Kuttiatt, Rahi and Kumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: PHILIP R. ABRAHAM, Vector Control Research Centre (ICMR), Puducherry, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.